Results 161 to 170 of about 2,216,425 (306)
Measures to strengthen international biosafety and biosecurity practices. [PDF]
Decroly E +19 more
europepmc +1 more source
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Practical guide to statistical reporting in optical imaging. [PDF]
Cheng X, Stephen EP, Yücel MA.
europepmc +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Outcome Reporting in Distal Radius Fracture Research: A Systematic Review Across Treatment Modalities. [PDF]
Blum E, Perugini JM, Mologne MS, Dy CJ.
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Predicting vesicoureteral reflux outcomes using artificial intelligence: A critical appraisal using APPRAISE-AI. [PDF]
Khondker A +8 more
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
QT-related adverse events with ondansetron and olanzapine: a real-world FAERS analysis with implications for oncology anti-emetic practice. [PDF]
Gandhi A, Parhizgar A, Bhise V.
europepmc +1 more source
An evaluation of the effect of the Common Reporting Standard on cross-border tax evasion
Omfanget og konsekvensene av skatteunndragelse på tvers av landegrensene vekker stor bekymring blant politiske beslutningstakere, og i løpet av de siste to tiårene har det blitt iverksatt betydelige tiltak for å fremme internasjonal skattetransparens.
openaire +1 more source

